Bovine leukaemia virus envelope peptides cause immunomodulation in BALB/c mice

Veterinary Immunology and Immunopathology

Volumn 68, Issue 1, 1999, Pages 39-48

  Kabeya, Hidenori ^a   Ohashi, Kazuhiko ^a   Sugimoto, Chihiro ^a   Onuma, Misao ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bovine leukaemia virus; Envelope peptide; Immunomodulation

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BOVINE LEUKEMIA VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; SPLEEN CELL; VETERINARY MEDICINE; VIRUS ENVELOPE;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; CONCANAVALIN A; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LEUKEMIA VIRUS, BOVINE; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDES; VIRAL ENVELOPE PROTEINS;

ANIMALIA; BOVINAE; BOVINE LEUKEMIA VIRUS; FELIDAE; LEUKAEMIA VIRUS;

EID: 0033614284     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(99)00005-7     Document Type: Article

References (21)

1. Cianciolo G.J., Copeland T.D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 230:1985;453-455.
2. Copelan E.A., Rinehart J.J., Lewis M., Mathes L., Olsen R., Sagone A. The mechanism of retrovirus suppression of human T cell proliferation in vitro. J. Immunol. 131:1983;2017-2020.
3. Gatei M.H., Good M.F., Daniel R.C., Lavin M.F. T-cell responses to highly conserved CD4 and CD8 epitopes on the outer membrane protein of bovine leukemia virus: relevance to vaccine development. J. Virol. 67:1993;1796-1802.
4. Gazzolo L., Duc Dodon M. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature. 326:1987;714-717.
5. Gottlieb R.A., Kleinerman E.S., O'Brian C.A., Tsujimoto S., Cianciolo G.J., Lennarz W.J. Inhibition of protein kinase C by a peptide conjugate homologous to a domain of the retroviral protein p15E. J. Immunol. 145:1990;2566-2570.
6. Haraguchi, S., Good, R.A., Day, N.K., 1995a. Immunosuppressive retroviral peptides: cAMP and cytokine patterns Immunol. Today 16, 595-603.
7. Haraguchi, S., Good, R.A., James-Yarish, M., Cianciolo, G.J., Day, N.K., 1995b. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc. Natl. Acad. Sci. U.S.A. 92, 3611-3615.
8. Haraguchi, S., Good, R.A., James-Yarish, M., Cianciolo, G.J., Day, N.K., 1995c. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc. Natl. Acad. Sci. U.S.A. 92, 5568-5571.
9. Hutchings D.L., Campos M., Qualtiere L., Babiuk L.A. Inhibition of antigen-induced and interleukin-2-induced proliferation of bovine peripheral blood leukocytes by inactivated bovine herpes virus 1. J. Virol. 64:1990;4146-4151.
10. Jensen W.A., Rovnak J., Cockerell G.L. In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep. J. Virol. 65:1991;2484-2490.
11. Jensen W.A., Wicks-Beard B.J., Cockerell G.L. Inhibition of protein kinase C results in decreased expression of bovine leukemia virus. J. Virol. 66:1992;4427-4433.
12. Kerkhofs P., Adam E., Droogmans L., Portetelle D., Mammerickx M., Burny A., Kettmann R., Willems L. Cellular pathways involved in the ex vivo expression of bovine leukemia virus. J. Virol. 70:1996;2170-2177.
13. Klasse P.J., Pipkorn R., Blomberg J. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc. Natl. Acad. Sci. U.S.A. 85:1988;5225-5229.
14. Luzzati A.L., Giacomini E., Giordani L., Pugliese O., Viora M., Chersi A. The antigen-specific induction of normal human lymphocytes in vitro is down-regulated by a conserved HIV p24 epitope. Immunol. Lett. 33:1992;307-314.
15. Manolios N., Collier S., Taylor J., Pollard J., Harrison L.C., Bender V. T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nature Medicine. 3:1997;84-88.
16. Mirsky M.L., Olmstead C.A., Da Y., Lewin H.A. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J. Virol. 70:1996;2178-2183.
17. Nelson M., Nelson D.S., Cianciolo G.J., Snyderman R. Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products. Cancer Immunol. Immunother. 30:1989;113-118.
18. Ruegg C.L., Monell C.R., Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63:1989;3257-3260.
19. Schlegel P.G., Aharoni R., Chen Y., Chen J., Teitelbaum D., Arnon R., Sela M., Chao N.J. A synthetic random basic copolymer with promiscuous binding to class II major histocompatibility complex molecules inhibits T-cell proliferative responses to major and minor histocompatibility antigens in vitro and confers the capacity to prevent murine graft-versus-host disease in vivo. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5061-5066.
20. Stone D.M., Hof A.J., Davis W.C. Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet. Immunol. Immunopathol. 48:1995;65-76.
21. Trueblood E.S., Brown W.C., Palmer G.H., Davis W.C., Stone D.M., McElwain T.F. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J. Virol. 72:1998;3169-3177.